Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03506308 · ClinicalTrials.gov registry record · NA
Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae
A NA study of Arteriovenous Fistula, sponsored by C. R. Bard.
- Active
- Registry status
- NA
- Development phase
- 213
- Enrollment target
- 20
- Study locations
NCT03506308 is a NA study of Arteriovenous Fistula that is active but no longer recruiting, run by C. R. Bard. The registered enrollment target is 213 participants, roughly in line with the 234-participant average among 7 other Arteriovenous Fistula trials with a reported enrollment target. The trial reports 20 study locations across 14 states.
The verdict
NCT03506308, a NA study of Arteriovenous Fistula, is active but no longer recruiting, sponsored by C. R. Bard.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 213 participants
- Enrollment target
- 20
- Study locations
Study Summary
This prospective, global, multicenter, single arm post-approval study is designed to investigate the clinical use and safety of the Lutonix® 035 AV Drug Coated Balloon (DCB) PTA Catheter in subjects presenting with clinical and hemodynamic abnormalities in native arteriovenous (AV) fistulae located in the upper extremity.
Conditions Studied
Interventions
- DEVICE LUTONIX 035 Drug Coated Balloon PTA Catheter
Study Locations (20)
Texas
- Dallas Vascular Center - Dallas
- HCA Houston Healthcare - Houston
- Houston Methodist Hospital - Houston
Alabama
- University of Alabama at Birmingham - Birmingham
- Flowers Hospital - Dothan
California
- St. Joseph Hospital of Orange - Orange
- Kaiser Permanente - San Diego
Louisiana
- Ochsner Health System - New Orleans
- Ochsner Louisiana State University Health - Shreveport
New York
- Columbia University Medical Center - New York
- Rochester General Hospital - Rochester
Connecticut
- Yale University - New Haven
Iowa
- University of Iowa Hospital and Clinics - Iowa City
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2018-08-07 |
| Est. Completion | 2030-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03506308
The ClinicalTrials.gov registry entry for NCT03506308 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 234-participant average among 7 other Arteriovenous Fistula trials with a reported enrollment target. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arteriovenous Fistula appearing as the primary indexed condition, and to 1 intervention - of which LUTONIX 035 Drug Coated Balloon PTA Catheter is the first listed.
NCT03506308 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Texas, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT03506308 about?
NCT03506308 is a clinical study titled "Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae". This prospective, global, multicenter, single arm post-approval study is designed to investigate the clinical use and safety of the Lutonix® 035 AV Drug Coated Balloon (DCB) PTA Catheter in subjects presenting with clinical and hemodynamic abnormalities in native arteriovenous (AV) fistulae located ...
What is the current status of trial NCT03506308?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 213 participants. The study started on 2018-08-07. Estimated completion is 2030-04.
What conditions does trial NCT03506308 study?
This clinical trial studies the following conditions: Arteriovenous Fistula.
What interventions are being tested in trial NCT03506308?
The interventions under investigation include: LUTONIX 035 Drug Coated Balloon PTA Catheter (DEVICE).
Who is sponsoring clinical trial NCT03506308?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03506308 being conducted?
This trial has 20 study locations across Alabama, California, Connecticut, Iowa, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arteriovenous Fistula
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
RECRUITING · NA
-
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
ACTIVE NOT RECRUITING · NA
-
Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
COMPLETED · NA
-
IN.PACT™ AV Access Post-Approval Study (PAS002)
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.